Literature DB >> 6843026

[Arterial retinal circulatory disorders: an urgent indication for Doppler sonographic study of the carotid flow system].

E B Ringelstein, N Körber, H Zeumer, W Hunold.   

Abstract

Nineteen subjects with retinal strokes of different degrees of severity (amaurosis fugax, occlusion of individual retinal arteries or of the central retinal artery) were examined by continuous-wave Doppler sonography. Evaluation of periorbital Doppler flow and direct examination of the major neck vessels were performed. Twelve subjects presented with homolateral arteriosclerotic lesions at the carotid bifurcation. The ultrasonographic findings were confirmed by carotid arteriography. High-grade stenosis or occlusion of the internal carotid artery were found in approximately 50% of the patients; the remainder turned out to have low-grade stenoses or nonstenosing plaques. These findings emphasize the role of emboli from the major neck arteries in the pathogenesis of retinal and cerebral insults. Hemodynamic effects seem to be of minor significance. Continuous-wave Doppler sonography is a completely non invasive, but nevertheless reliable method for the detection of clinically relevant carotid lesions. Especially patients suffering from retinal insults should be examined by Doppler sonography, since they are at high risk for further cerebral stroke.

Entities:  

Mesh:

Year:  1983        PMID: 6843026     DOI: 10.1055/s-2008-1054730

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  2 in total

1.  Survival prognosis of patients with retinal artery occlusion and associated carotid artery disease.

Authors:  P De Potter; L Zografos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-04       Impact factor: 3.117

2.  Carotid arteries in central retinal vessel occlusion as assessed by Doppler ultrasound.

Authors:  P Peternel; D Keber; V Videcnik
Journal:  Br J Ophthalmol       Date:  1989-11       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.